NFKB1 and Burkitt lymphoma: In agreement with our previous finding that PL kills human BL and mouse BL-like cells by virtue of a mechanism that includes inhibition of NF-κB [13,16], we found that PL kills 3 of 3 BL lines with similar efficacy (Figure 4D, top).